neoplasms chemotherapy AIDS acquired immunodeficiency syndrome mycotoxins allergens Fungal infections opportunisitic pathogens accidental phenomenon

Similar documents
Voriconazole. Voriconazole VRCZ ITCZ

Table 1. Antifungal Breakpoints for Candida. 2,3. Agent S SDD or I R. Fluconazole < 8.0 mg/ml mg/ml. > 64 mg/ml.

About the Editor Gerri S. Hall, Ph.D.

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

number Done by Corrected by Doctor د.حامد الزعبي

Introduction. Study of fungi called mycology.

In Vitro Studies with R 51,211 (Itraconazole)

Management of fungal infection

C.V. Parvin Dehghan. Director & head of Mycology and Parasitology Dep. ( ) Faculty of Medicine, Isfahan University of Medical Sciences

Ali Alabbadi. Sarah Jaar ... Nader

Update zu EUCAST 2012 Cornelia Lass-Flörl

Antifungal drugs Dr. Raz Muhammed

Introduction Medical Mycology. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan

TEPZZ Z9Z74_A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION

PREVALANCE OF CANDIDIASIS IN CHILDREN IN MUMBAI

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

PREVALANCE OF CANDIDIASIS IN CHILDREN IN MUMBAI

ANA ESPINEL-INGROFF* Division of Infectious Diseases, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia

Antifungal therapies differences in agents

Evaluation of in Vitro Antifungal Activity of Ketoconazole and Griseofulvin

Prevalence of Oral Thrush Yeasts among School Children with special emphasis of Fluconazole antifungal drug

ANTIMYCOTIC DRUGS Modes of Action

Trichophyton Microsporum Epidermophyton. dermatomycosis. Dematiaceous(pigmented fungi ) Dimorphic fungi Yeast and yeast like saprophyte

Speciation of Candida Isolated from Various Clinical Samples and their Antifungal Susceptibility Profile in a Tertiary Care Hospital

Candida auris: an Emerging Hospital Infection

Antifungal Resistance in Asia: Mechanisms, Epidemiology, and Consequences

Dr Hamed Alzoubi. Fungal infections

Isolation of the Fungal Samples from the Patient's Skin in Vijayawada City Hospital, Andhra Pradesh, India

AUSTRALIAN ANTIFUNGAL SUSCEPTIBILITY DATA : PART 2 THE MOULDS ASPERGILLUS, SCEDOSPORIUM AND FUSARIUM.

International Journal of Health Sciences and Research ISSN:

number Done by Corrected by Doctor

Received 18 December 2008/Returned for modification 9 February 2009/Accepted 9 April 2009

Isolates from a Phase 3 Clinical Trial. of Medicine and College of Public Health, Iowa City, Iowa 52242, Wayne, Pennsylvania ,

Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan

number Done by Corrected by Doctor

Identification of Yeasts. Medical Mycology Training Network 15 November 2018 Dr Tan Ai Ling Department of Microbiology, Singapore General Hospital

Int.J.Curr.Microbiol.App.Sci (2014) 3(10)

Staphylococci. Gram stain: gram positive cocci arranged in clusters.

Medical Mycology. Dr. Hala Al Daghistani

CANDIDIASIS (WOMEN) Single Episode. Clinical Features. Diagnosis. Management

dida tropicalis, Candida parapsilosis, Candida krusei, Cr. neoformans

International Journal of Health Sciences and Research ISSN:

EUCAST-AFST Available breakpoints 2012

SYNERGISTIC ACTIVITIES OF TWO PROPOLIS WITH AMPHOTERICIN B AGAINST SOME AZOLE-RESISTANT CANDIDA STRAINS. PART II

Antifungal Susceptibility of Candida

Prevalence, Distribution, Risk factors and Antifungal Susceptibility Profiles of Candida species in a Tertiary Care Hospital

Correlation of culture with histopathology in fungal burn wound colonization and infection

Candida albicans. Habitat, Morphology, Cultural Characteristics, Life Cycle, Pathogenesis, Lab Diagnosis, Treatments, Prevention and Control

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

ISSN Vol.02,Issue.19, December-2013, Pages:

Original Article Characterization of candida species isolated from cases of lower respiratory tract infection

Antifungal Susceptibility Testing

Opportunistic Mycoses

Dermatophytes and other fungi associated with hair-scalp of Primary school children in Visakhapatnam, India: A Case Study And Literature Review

Candida albicans 426 (64.0 ) C. albicans non-albicans

Department of Animal Production, Faculty of Agriculture, Baghdad University, Baghdad, Iraq

Mycological Profile of Chronic Suppurative Otitis Media in a Tertiary Care Hospital in South India

Isolation, speciation and antifungal susceptibility patterns of candida isolated from cases of chronic balanoposthitis

Comparison of microdilution method and E-test procedure in susceptibility testing of caspofungin against Candida non-albicans species

Medical Mycology. Dr. Hala Al Daghistani

ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS

1* 1. Vijaya S. Rajmane, Shivaji T. Mohite

Downloaded from Candiduria In Immunocompromised Individuals In A Tertiary Care Center In Northern India

Occurrence of Drug Resistant Candida Species in the Sputum of TB Clinic Attendees in and Around Chidambaram, Tamilnadu, India

National Center for Emerging and Zoonotic Infectious Diseases AR Lab Network Candida Testing

Received 22 November 2007/Returned for modification 29 December 2007/Accepted 12 January 2008

Treatment of rare and emerging fungal infections. EFISG Educational Workshop 15 th ECCMID April 2, 2005, Copenhagen

Antifungal Pharmacotherapy

Comparative In Vitro Antifungal Activity of Amphotericin B and Amphotericin B Methyl Ester

9/18/2018. Invasive Candidiasis. AR Lab Network Candida Testing. Most Common Healthcare Associated Bloodstream Infection in the United States?

Fluconazole Susceptibility Profile of Candida isolates Recovered from Patients Specimens Admitted to Yazd Central Laboratory

Prevalence of Nondermatophytes in Clinically Diagnosed Taeniasis

Laboratory evaluation for determining posaconazole susceptibility of fungi isolated in denture stomatitis

Case Studies in Fungal Infections and Antifungal Therapy

A class IIa medical device intended for mild-to-moderate fungal nail infection PRODUCT MONOGRAPH

Comparison of in vitro antifungal activities of efinaconazole and. currently available antifungal agents against a variety of pathogenic

Antifungals and current treatment guidelines in pediatrics and neonatology

Antifungal Potential of Disulfiram

The Differentiation of Yeast and Yeast-Like Forms in Human Tissues. Introduction. Histochemical Stains Used to Detect Fungi. Histopathologic Diagnoses

Antifungal susceptibility testing: Which method and when?

Dermatophytes Dr. Hala Al Daghistani

The Effect of Dimethyl Sulfoxide DMSO on the Growth of Dermatophytes

Use of Antifungal Drugs in the Year 2006"

FLUCONAZOLE AND BORIC ACID FOR TREATMENT OF VAGINAL CANDIDIASIS- NEW WORDS ABOUT OLD ISSUE

Common Fungi. Catherine Diamond MD MPH

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

How Can We Prevent Invasive Fungal Disease?

All three dermatophytes contain virulence factors that allow them to invade the skin, hair, and nails. Keratinases. Elastase.

Updated Guidelines for Management of Candidiasis. Vidya Sankar, DMD, MHS April 6, 2017

Japan Antifungal Surveillance Program (1):

An Update in the Management of Candidiasis

High incidence of onychomycosis due to saprophytic fungi in Yazd, Iran

Mycology Reference Centre, Leeds Information for Service Users 2017

Clinical Practice Guideline Superficial Fungal Infection

PHARMACEUTICAL CHEMISTRY II (PHCM672) Lecture 1, Antifungal Drugs (Antimycotics) Dr. Mohammad Abdel-Halim

Mycological Profile of Bronchial Wash Specimens in Patients with Lower Respiratory Tract Infections

Antifungal resistance mechanisms in pathogenic fungi

Pharmaceutical Chemistry II. Antifungal Agents. = Antimycotics. Tutorial 1

Transcription:

00 0. (SDA) C. 0 C. tropicalis albicans 0. sp Ketoconazole Fluconazole Agar dilution method. 00 Miconazole Lugol's Iodine Iodine Gentian violet C. glabrata. krusei Miconazole Ketoconazole Phenol Povidone-Iodine neoplasms chemotherapy AIDS acquired immunodeficiency syndrome accidental phenomenon mycotoxins allergens Fungal infections opportunisitic pathogens immunological status malignant

C. C. krusei C. C. Kefyr C. tropicalis parapsilosis C. guilliermondii glabrata C. C. parapsilosis Endocarditis albicans C. glabrata candidiasis C. tropicalis disseminated candidiasis Bennett Kown Chung environmental factors Rippon subacute acute chronic septicemia Endocarditis meningitis Ellis onychomycosis Midgely Minimal Inhibitory Concentration MFC Minimal Fungicidial Concentration Yeast like fungi pseudohyphae 00 Kolarik Normal Anderson, 0 budding flora (Ellis, ; 0 McGinnis 00 0 00 B antihistamines Systemic Candidiasis, 00 C. albicans 0

00 00 0 Buckley 0 McGinnis Ellis Germ tube formation test Chlamydospores formation test Guient Kreger Van Rij Agar dilution Baron Finegold 0 McGinnis method () Gugnani Okeke Fungal isolates C. albicans C. C. krusei tropicalis sp. glabrata Fungal inoculum sterillized cotton swab 0 Ellis 0 wireloop SDA Culture 0 Neubauer counting Chamber

Determination of and MFC Agar dilution method Gugnani Okeke 0 McGinnis () 0000 SDB 000 Working Solution SDB 0 SDB 0. SDA 0.0 00 Test media.0 ph. SDA Antifungal drugs (Fugidin) SDI Miconazole SDI Fluconazole Ketoconazole Stock 0000 solution 00 DMSO DMSO 0000 0 0 DMSO

00 00.... 0. 0. 0 0. 0. 0.0 0.0 0.00 Dmso 0.00 0.00 Evaluation of disinfectants Phenol coefficient tests Fungal isolates albicans C.krusei Disinfectants Phenol.. 0 0.. Iodine.. 0.. 0 0. 0. Povidone Iodine 0 0

) Lugol's iodine.. ( 0 0.. Gentian violet.). 0. :(. 0. 0. Hugo Russell 0. 0. 0 00 0.. 0. SDA L 00 Result 0 0 SDA

00 C. albicans albicans 0 C. krusei C. tropicalis 0 tropicalis sp. glabrata 0 albicans C. krusei sp.

0 albicans 0 C. tropicalis 0 C. krusei. C. glabrata sp. 0. Miconazole Fluconazole Ketoconazole Ketoconazole.. 00... 00. Fluconazole........ Miconazole 0..... MFC MFC

00 (ug/ml) 0.0 0. 0. 0. 0..... 00 00c ( ) M 00<-. F 00-0. C.-. N 00-. K.-. ( ) M 00-0. F.- 0. C.-. N 00-0. K 0.- 0. C. glabrata ( ) M 00 F C 0.- 0. N.-. K.-. C. krusei ) M. 00

F 00-. C.-. N 00- K.-. sp. ( ) M F C 0.0 N 00 K 0.0 Miconazole 0. Fluconazole 0 0 0 0 0 0 Ketoconazole

00 MFC Miconazole Fluconazole Ketoconazol e MFC MFC MFC MFC MFC.. 0. 0....... 0. 0................. 00 00.... 00 00.. 00. 00 00 00 00... 00 00 00 00. 00 00 00. 0. 0. 0. 0. 0. 0..... 0. 0... 0. 0....... 0. 0. 00 00. 00 00.. 0. 0. 00 00. 00 00.... 0. 0. 00 00.... 0. 0. C.krusei............ 00 00.. 00 00.. 00 00.. sp. 0.0 0.0 00 00 0.0 0.0 Gentian violet Lugol's Iodine Iodine phenol povidone Iodine... C. albicans. C. tropicalis C. glabrata. C. krusei.. 0. 0.0

........0 povidone Iodine 00.. 0.. 0.. 0.. 0. C.krusei. 0. Gentian violet.. 0..... 0.... C.krusei.. 0 Lugol's Iodine.. 0.0......0.. C.krusei...

00 0 () Graner Paetzold Ellis 0 McGinnis. C.krusei 0 0. sp. Ghannoum 0. C. albicans DiSilverio Ellis Al-Duboon C. albicans. Alicja Budak

0 0

00 Gon Eukaryotic Organisms McGinnis 0 In vitro Espinal Ingroff Miconazole Fluconazole Ketoconazole Ketoconazole. 00. Wildfeuer 00. 00. Al-Duboon. Khudor.. 00 0 0 0 0. 00 Fluconazole.... 00 0 0 0 Fluconazole..... Ghannoum 00 Al-Duboon. 00 Khudor... Miconazole 0.... Lister antiseptic standard Rideal walker Chick Martin

Hugo Russell.. 0. 0 Scott. 000 Alternaria alternata Aspergillus candidus A.chlamydospora A. niger A. fumigatus A. flavus C.cifferrii albicans C. Chrysosporium keratinophilum Sporothrix schenckii tropicum 00. povidone iodine 00 0 C.krusei 0 Scott. 0 Povidone-iodine T. mentagrophytes Hugo Russell gentian povidone-iodine phenol iodine Lugol's iodine violet.. C.krusei Scott albicans Aspergillus Trichophyton mentagrophytes 0. niger. I Lugol's Solution

00 cows in Basrah/ Iraq. The Veterinan, vol. 0, (). P -. Alicja Budak, Macuta, A.B., Nazur, T. and zofia Laskownika (). Fungal species isolated from skin and nail lesions of hands and feet of patients suspected of mycotic infections. mykosen, 0:-. Anderson, J.R. (0). Muri's textbook of pathology. th ed. Edwarde Arnold, Norwich, U.K. 0p. Buckley, H.R.(). Identification of yeasts. In: Medical mycology. A practical approach. Evans, E.G. and Richaroach, M.D.(eds) I.RL.Press, Oxford University press. p : -0 Ellis, D.H. (). Clinical mycology. The human opportunistic mycoses. Pfizer, New York. P. Espinel- Ingroff, A.(). Standardization of antifungal susceptibility testing. Review update, Revista Iberoamerican de Micologia, :- Finegold S.M. & Baron E.J.(). Bailey and scott's Diagnostic Microbiology. th ed. The C.V Mosby company. St.Louis Toronto. princeton. p. Ghannoum, M.A.; Sharif, H.F.& AL- Gharreer, H.(). Sensitivity of clinical yeast isolates in kuwait against a number of antifungal agents. Mykosen, :0-0 A. niger. Lugol's 0 Povidone iodine Iodine gentian violet.. 0. C. albicans C. glabrata C.krusei 00 Al-Duboon, A.H. (). A study on superficial cutaneous mycoses in Basrah (Iraq), Ph.D. thesis, College of Science, University of Basrah. p. Al-Duboon, A.H. Abdul-Aziz, J.M. and Abdullah, S.K. (000). The Effict of five Antimycotic drugas against some fungi isolated from hair of

medical mycology. Mosby-wolfe, an imprint of mosby international, Spain, p Okeke, C.N. & Gugnani, H.C.(). In vitro sensitivity of environmental isolated of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-mpholine derivative. Mycopathologia, :-. Paetzold, O.H. and Garner, E. (). Incidence of different species in infections observed in the Department of Dermatology, University of kiel, Mykosen, :-. Rippon, J.W. (). Medical Mycology. rd ed. W.B. Saunders Co., Philadelphia, USA. Wildfeuer, A.; Seidl,H.p.; Paule, I. and Haberreiter, A.(). In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses, :0-. Gon, C.L; Tay, Y.k.; Ali, K.B., koh, M.T. & seow, C.S. (). In vitro evaluation of griseofuvin, ketoconzole and itraconazole against various dermatophytes in Singapore. Int. J.Dermatol. :- Hugo W.B & Russell A.D. (). Pharmaceutical Microbiology. Black well Scientific publications th ed, London. p. Khudor, M.H.(). A study on vaginal candidiasis in Basrah women and effect of five antifungal drugs on some clinical isolated. M.Sc. Thesis, College of Science, University of Basrah. p. Kreger-Van Rij, N.J.W. (). The yeasts. A taxnomic study. ed Elsevier, Amestevdam.PP -. Kwon-Chung, K.J. and Bennett, J.E.(). Medical mycology. Lea& Febiger, Philadelphia and London. Pp. McGinnis, M.R.(0). Laboratory hand book of medical mycology Academic press, New York, USA, p Midgley, G.;Clayton, Y.M. and Hay, R.J.(). Diagnosis in color 0

00 MUCO CUTANEOUS CANDIDIASIS IN BASRAH INFANTS A. H. Al-Duboon ; K. K. Al-Rubaiy and L. K. Muhsin - Basrah University/ Marine Science Center - Basrah University/ College of Medicine - Basrah University/ Unit of Electron Microscope Summary A total of clinical specimens were collected from infants ( males and females) aged from month to years from Basrah General Hospital and Basrah Maternatily and children Hospital. The collected specimens were examind for etiologic agents by direct microscopy (KOH- mounting) and culture on suitable culture media. Five species of were isolated and identified as: albicans (%), C. tropicalis (0%), C. krusei (.%), C. glabrata (%) and sp. ( 0.%). The study was also conducted to determine the minimal inhibitory concentration () for the antifungals: clotrimazole, miconazole, nystatin, fluconazole and ketoconazole by the agar dilution method against the isolated species. Ketoconazole was the most effective antifungal inhibit 00% of the isolates at a concentration of. ug/ml. came after Ketoconazole and Miconazole was the least effective drug. The activity of five antiseptics (phenol, Iodine, Povidone- iodine, gentian-violet and Lugol's-iodine) were also tested and the phenol was the most effective one against isolates of.